Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Michel

Showing results (71-80 of 282) with videos related to

Pageof 29
Sort By:
Urology|October 13, 2001
Worldwide experience with alfuzosin and tamsulosinM C Michel, M T Flannery, P Narayan
Conference Proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference|February 3, 2007
Creating a text data-mining application for use in public health informaticsM C Michel, L A Bero, T Bright
Clinical Physiology and Biochemistry|January 1, 1990
Subtype-selective modulation of human beta 1- and beta 2-adrenoceptor function by beta-adrenoceptor agonists and antagonistsO E Brodde, A Daul, M C Michel
European Journal of Pharmacology|August 1, 1996
Cytoskeletal inhibitors impair Ca2+ elevations via neuropeptide Y and other Gi-coupled receptorsM C Michel, S Kaldenberg-Stasch, T Wieland
Der Urologe. Ausg. A|November 13, 2002
[alpha 1-receptor blockade in therapy of benign prostatic hyperplasia syndrome. Correct dosing for optimal effectiveness]R R Berges, M C Michel, U Jonas
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 1, 1995
Classification of alpha 1-adrenoceptor subtypesM C Michel, B Kenny, D A Schwinn
Life Sciences|January 1, 1994
Is SDZ NVI-085 an alpha 1-adrenoceptor subtype-selective agonist?R Büscher, P A Insel, M C Michel
Pflugers Archiv : European Journal of Physiology|December 11, 1999
Is bradykinin a mediator of renal neuropeptide Y effects?A Bischoff, A Neumann, A Dendorfer, et al.
Molecular Pharmacology|January 1, 1990
Amplification of cyclic AMP generation reveals agonistic effects of certain beta-adrenergic antagonistsJ R Jasper, M C Michel, P A Insel
Canadian Journal of Physiology and Pharmacology|March 29, 2000
Pharmacology and quantitative structure-activity relationships of imidazolylpropylguanidines with mepyramine-like substructures as non-peptide neuropeptide Y Y1 receptor antagonistsS Dove, M C Michel, S Knieps, et al.
Pageof 29

Showing results (71-80 of 282) with videos related to

Sort By:
Pageof 29
Urology|October 13, 2001
Worldwide experience with alfuzosin and tamsulosinM C Michel, M T Flannery, P Narayan
Conference Proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference|February 3, 2007
Creating a text data-mining application for use in public health informaticsM C Michel, L A Bero, T Bright
Clinical Physiology and Biochemistry|January 1, 1990
Subtype-selective modulation of human beta 1- and beta 2-adrenoceptor function by beta-adrenoceptor agonists and antagonistsO E Brodde, A Daul, M C Michel
European Journal of Pharmacology|August 1, 1996
Cytoskeletal inhibitors impair Ca2+ elevations via neuropeptide Y and other Gi-coupled receptorsM C Michel, S Kaldenberg-Stasch, T Wieland
Der Urologe. Ausg. A|November 13, 2002
[alpha 1-receptor blockade in therapy of benign prostatic hyperplasia syndrome. Correct dosing for optimal effectiveness]R R Berges, M C Michel, U Jonas
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 1, 1995
Classification of alpha 1-adrenoceptor subtypesM C Michel, B Kenny, D A Schwinn
Life Sciences|January 1, 1994
Is SDZ NVI-085 an alpha 1-adrenoceptor subtype-selective agonist?R Büscher, P A Insel, M C Michel
Pflugers Archiv : European Journal of Physiology|December 11, 1999
Is bradykinin a mediator of renal neuropeptide Y effects?A Bischoff, A Neumann, A Dendorfer, et al.
Molecular Pharmacology|January 1, 1990
Amplification of cyclic AMP generation reveals agonistic effects of certain beta-adrenergic antagonistsJ R Jasper, M C Michel, P A Insel
Canadian Journal of Physiology and Pharmacology|March 29, 2000
Pharmacology and quantitative structure-activity relationships of imidazolylpropylguanidines with mepyramine-like substructures as non-peptide neuropeptide Y Y1 receptor antagonistsS Dove, M C Michel, S Knieps, et al.
Pageof 29